ClinConnect ClinConnect Logo
Search / Trial NCT06149845

Pulpotomy in Vital Primary Molars Diagnosed With Symptomatic Irreversible Pulpitis

Launched by QATAR UNIVERSITY · Nov 25, 2023

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Pulpotomy

ClinConnect Summary

This clinical trial is studying a dental procedure called pulpotomy, which is used to treat young children with a painful condition known as irreversible pulpitis in their primary molars, or baby teeth. Pulpotomy is a simpler and less invasive treatment compared to the traditional method, called pulpectomy. The goal of the study is to see how well pulpotomy works for children, as it is generally easier for them to handle and helps keep the tooth's natural feeling intact.

To participate in this trial, children aged four to nine years who are healthy and show signs of irreversible pulpitis in one of their primary molars may be eligible. It's important that the affected tooth is still alive and that there are no signs of severe infection. Parents should be willing to have their child receive a full coverage crown after the procedure. If your child is experiencing tooth pain and meets these criteria, they may be a good fit for the study, which is currently looking for participants.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Healthy (ASA I and II) co-operative children (Frankl Scale + and ++) between the ages of four and nine years.
  • 2. Participants have symptoms typical of irreversible pulpitis in one of the primary molars.
  • 3. The pulp of the affected primary molar is vital.
  • 4. Radicular pulp health is confirmed by attainment of radicular pulp haemostasis within 6 minutes of coronal pulp amputation.
  • 5. The affected primary molars can be restored with full coverage crowns.
  • 6. Any physiologic root resorption, if present, is less than ⅓ the root length
  • Exclusion Criteria:
  • 1. Clinical examination of affected primary molar reveals signs of pulpal infection (e.g.
  • pathologic tooth mobility, parulis/fistula, or soft tissue swelling)
  • 2. Pre-operative periapical radiograph suggests presence of periapical radiolucency.
  • 3. Pre-operative periapical radiograph suggests presence of furcal radiolucency more than ½ the furcation to periapical area.
  • 4. Visual examination of pulp tissue after deroofing reveals signs of necrosis (e.g.
  • avascular/minimally bleeding pulp tissue or yellowish necrotic areas/purulent exudate).
  • 5. Signs of extensive radicular pulp inflammation.
  • 6. Parents not willing to place full coverage crowns post-pulpotomy.
  • 7. Clinical diagnosis of irreversible pulpitis between two teeth is not sharply defined.

About Qatar University

Qatar University is a leading academic institution dedicated to advancing research and innovation across various fields, including healthcare and clinical sciences. As a clinical trial sponsor, Qatar University leverages its robust academic resources and expertise to conduct rigorous research aimed at improving health outcomes and addressing public health challenges. The university fosters collaboration among multidisciplinary teams, promoting the integration of cutting-edge scientific knowledge with practical applications. Through its commitment to ethical research practices and adherence to regulatory standards, Qatar University aims to contribute meaningful insights to the global medical community while enhancing the quality of care for diverse populations.

Locations

Doha, , Qatar

Doha, , Qatar

Patients applied

0 patients applied

Trial Officials

Nebu Philip, PhD

Principal Investigator

Qatar University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported